polymers for biomedicine - download.e-bookshelf.de · 2 31poly(2‐oxazoline): the structurally...
TRANSCRIPT
Polymers for Biomedicine
Polymers for Biomedicine
Synthesis, Characterization, and Applications
Edited byCarmen Scholz
University of Alabama in HuntsvilleAlabama, USA
This edition first published 2017© 2017 John Wiley & Sons, Inc
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions.
The right of Carmen Scholz to be identified as the Editor of this work has been asserted in accordance with law.
Registered OfficeJohn Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, USA
Editorial Office111 River Street, Hoboken, NJ 07030, USA
For details of our global editorial offices, customer services, and more information about Wiley products visit us at www.wiley.com.
Wiley also publishes its books in a variety of electronic formats and by print‐on‐demand. Some content that appears in standard print versions of this book may not be available in other formats.
Limit of Liability/Disclaimer of WarrantyIn view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of experimental reagents, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each chemical, piece of equipment, reagent, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. While the publisher and authors have used their best efforts in preparing this work, they make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives, written sales materials or promotional statements for this work. The fact that an organization, website, or product is referred to in this work as a citation and/or potential source of further information does not mean that the publisher and authors endorse the information or services the organization, website, or product may provide or recommendations it may make. This work is sold with the understanding that the publisher is not engaged in rendering professional services. The advice and strategies contained herein may not be suitable for your situation. You should consult with a specialist where appropriate. Further, readers should be aware that websites listed in this work may have changed or disappeared between when this work was written and when it is read. Neither the publisher nor authors shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.
Library of Congress Cataloging‐in‐Publication DataNames: Scholz, Carmen, 1963– editor.Title: Polymers for biomedicine : synthesis, characterization, and applications /
edited by Carmen Scholz.Description: Hoboken, New Jersey : John Wiley & Sons, Inc., 2017. | Includes bibliographical
references and index.Identifiers: LCCN 2017012622 (print) | LCCN 2017005426 (ebook) | ISBN 9781118966570 (cloth) |
ISBN 1118966570 (cloth) | ISBN 9781118967935 (Adobe PDF) | ISBN 9781118967881 (ePub)Subjects: LCSH: Polymers. | Polymerization. | Polymers in medicine. | Macromolecules.Classification: LCC QD381 .P61244 2017 (ebook) | LCC QD381 (print) | DDC 610.28/4–dc23LC record available at https://lccn.loc.gov/2017012622
Cover image: WileyCover design by (Molecular structure) © nopparit/Gettyimages; (DNA) Ingram Publishing/Gettyimages
Set in 10/12pt Warnock by SPi Global, Pondicherry, India
Printed in United States of America
10 9 8 7 6 5 4 3 2 1
v
List of Contributors ix
Part I Pseudo‐Peptides, Polyamino Acids, and Polyoxazolines 1
1 Characterization of Polypeptides and Polypeptoides – Methods and Challenges 3David Huesmann and Matthias Barz
2 Poly(2‐Oxazoline): The Structurally Diverse Biocompatibilizing Polymer 31Rodolphe Obeid
3 Poly(2‐Oxazoline) Polymers – Synthesis, Characterization, and Applications in Development of POZ Therapeutics 51Randall W. Moreadith and Tacey X. Viegas
4 Polypeptoid Polymers: Synthesis, Characterization, and Properties 77Brandon A. Chan, Sunting Xuan, Ang Li, Jessica M. Simpson, Garrett L. Sternhagen, and Donghui Zhang
Part II Advanced Polycondensates 121
5 Polyanhydrides: Synthesis and Characterization 123Rohan Ghadi, Eameema Muntimadugu, Wahid Khan, and Abraham J. Domb
6 New Routes to Tailor‐Made Polyesters 149Kazuki Fukushima and Tomoko Fujiwara
7 Polyphosphoesters: An Old Biopolymer in a New Light 191Kristin N. Bauer, Hisaschi T.C. Tee, Evandro M. Alexandrino, and Frederik R. Wurm
Contents
Contentsvi
Part III Cationically Charged Macromolecules 243
8 Design and Synthesis of Amphiphilic Vinyl Copolymers with Antimicrobial Activity 245Leanna L. Foster, Masato Mizutani, Yukari Oda, Edmund F. Palermo, and Kenichi Kuroda
9 Enhanced Polyethylenimine‐Based Delivery of Nucleic Acids 273Jeff Sparks, Tooba Anwer, and Khursheed Anwer
10 Cationic Graft Copolymers for DNA Engineering 297Atsushi Maruyama and Naohiko Shimada
Part IV Biorelated Polymers by Controlled Radical Polymerization 313
11 Synthesis of (Bio)degradable Polymers by Controlled/“Living” Radical Polymerization 315Shannon R. Woodruff and Nicolay V. Tsarevsky
Part V Polydrugs and Polyprodrugs 355
12 Polymerized Drugs – A Novel Approach to Controlled Release Systems 357Bahar Demirdirek, Jonathan J. Faig, Ruslan Guliyev, and Kathryn E. Uhrich
13 Structural Design and Synthesis of Polymer Prodrugs 391Petr Chytil, Libor Kostka, and Tomáš Etrych
Part VI Biocompatibilization of Surfaces 421
14 Polymeric Ultrathin Films for Surface Modifications 423Henning Menzel
15 Surface Functionalization of Biomaterials by Poly(2‐oxazoline)s 457Giulia Morgese and Edmondo M. Benetti
16 Biorelated Polymer Brushes by Surface Initiated Reversible Deactivation Radical Polymerization 487Rueben Pfukwa, Lebohang Hlalele, and Bert Klumperman
Contents vii
Part VII Self‐Assembled Structures and Formulations 525
17 Synthesis of Amphiphilic Invertible Polymers for Biomedical Applications 527Ananiy M. Kohut, Ivan O. Hevus, Stanislaw A. Voronov, and Andriy S. Voronov
18 Bioadhesive Polymers for Drug Delivery 559Eneko Larrañeta and Ryan F. Donnelly
Index 603
ix
Evandro M. AlexandrinoMax Planck Institute for Polymer Research (MPIP)Mainz, Germany
Khursheed AnwerCelsion CorporationHuntsville, AL, USA
Tooba AnwerUniversity of Alabama at BirminghamBirmingham, AL, USA
Matthias BarzInstitute of Organic ChemistryJohannes Gutenberg‐Universität MainzMainz, Germany
Kristin N. BauerMax Planck Institute for Polymer Research (MPIP)Mainz, Germany
Edmondo M. BenettiLaboratory for Surface Science and TechnologyDepartment of MaterialsETH ZürichZürich, Switzerland
Brandon A. ChanDepartment of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge, LA, USA
Petr ChytilInstitute of Macromolecular ChemistryAcademy of Sciences of the Czech RepublicPrague, Czech Republic
Bahar DemirdirekDepartment of Chemistry and Chemical BiologyRutgers UniversityPiscataway, NJ, USA
Abraham J. DombSchool of Pharmacy‐Faculty of MedicineThe Hebrew University of Jerusalem, and Jerusalem College of Engineering (JCE)Jerusalem, Israel
Ryan F. DonnellySchool of PharmacyQueen’s University BelfastBelfast, UK
List of Contributors
List of Contributorsx
Tomáš EtrychInstitute of Macromolecular ChemistryAcademy of Sciences of the Czech RepublicPrague, Czech Republic
Jonathan J. FaigDepartment of Chemistry and Chemical BiologyRutgers UniversityPiscataway, NJ, USA
Leanna L. FosterMacromolecular Science and Engineering CenterUniversity of MichiganAnn Arbor, MI, USA
Tomoko FujiwaraDepartment of ChemistryUniversity of MemphisMemphis, TN, USA
Kazuki FukushimaDepartment of Polymeric and Organic Materials EngineeringYamagata University, Yonezawa, Yamagata, Japan
Rohan GhadiDepartment of PharmaceuticsNational Institute of Pharmaceutical Education and Research (NIPER)Hyderabad, India
Ruslan GuliyevDepartment of Chemistry and Chemical BiologyRutgers UniversityPiscataway, NJ, USA
Ivan O. HevusDepartment of Coatings and Polymeric MaterialsNorth Dakota State UniversityFargo, ND, USA
Lebohang HlaleleDepartment of Chemistry andPolymer ScienceStellenbosch UniversityMatieland, South Africa
David HuesmannInstitute of Organic ChemistryJohannes Gutenberg‐ Universität MainzMainzGermany
Wahid KhanDepartment of PharmaceuticsNational Institute of Pharmaceutical Education and Research (NIPER)Hyderabad, India
Bert KlumpermanDepartment of Chemistry and Polymer ScienceStellenbosch UniversityMatieland, South Africa
Ananiy M. KohutDepartment of Organic ChemistryLviv Polytechnic National UniversityLviv, Ukraine
Libor KostkaInstitute of Macromolecular ChemistryAcademy of Sciences of the Czech RepublicPrague, Czech Republic
List of Contributors xi
Kenichi KurodaMacromolecular Science and Engineering Center andDepartment of Biologic and Materials SciencesSchool of DentistryUniversity of MichiganAnn Arbor, MI, USA
Eneko LarrañetaSchool of PharmacyQueen’s University BelfastBelfast, UK
Ang LiDepartment of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton RougeLA, USA
Atsushi MaruyamaDepartment of Life Science and TechnologyTokyo Institute of Technology Yokohama, Japan
Henning MenzelInstitut für Technische ChemieTechnische Universität BraunschweigBraunschweig, Germany
Masato MizutaniDepartment of Chemistry and Chemical BiologyBaker LaboratoryCornell UniversityIthaca, NY, USA
Randall W. MoreadithSerina TherapeuticsHuntsville, AL, USA
Giulia MorgeseLaboratory for Surface Science and TechnologyDepartment of MaterialsETH ZürichZürich, Switzerland
Eameema MuntimaduguDepartment of PharmaceuticsNational Institute of Pharmaceutical Education and Research (NIPER)Hyderabad, India
Rodolphe ObeidR&D/Process Development & Manufacturing Scale‐Up, IntelGenx Corp.St. LaurentQuebecCanada
Yukari OdaDepartment of Applied ChemistryKyushu UniversityFukuoka, Japan
Edmund F. PalermoDepartment of Materials Science and EngineeringRensselaer Polytechnic InstituteTroy, NY, USA
Rueben PfukwaDepartment of Chemistry and Polymer ScienceStellenbosch UniversityMatieland, South Africa
List of Contributorsxii
Naohiko ShimadaDepartment of Life Science and TechnologyTokyo Institute of TechnologyYokohama, Japan
Jessica M. SimpsonDepartment of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge, LA, USA
Jeff SparksCelsion CorporationHuntsville, AL, USA
Garrett L. Sternhagen Department of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge, LA, USA
Hisaschi T.C. TeeMax Planck Institute for Polymer Research (MPIP)Mainz, Germany
Nicolay V. TsarevskyDepartment of Chemistry and Center for Drug Discovery, Design, and Delivery, Southern Methodist UniversityDallas, TX, USA
Kathryn E. UhrichDepartment of Chemistry and Chemical BiologyRutgers UniversityPiscataway, NJ, USA
Andriy S. VoronovDepartment of Coatings and Polymeric MaterialsNorth Dakota State UniversityFargo, ND, USA
Stanislaw A. VoronovDepartment of Organic ChemistryLviv Polytechnic National UniversityLviv, Ukraine
Tacey X. ViegasSerina TherapeuticsHuntsville, AL, USA
Shannon R. WoodruffDepartment of Chemistry and Center for Drug Discovery, Design, and Delivery, Southern Methodist UniversityDallas, TX, USA
Frederik R. WurmMax Planck Institute for Polymer Research (MPIP)Mainz, Germany
Sunting XuanDepartment of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge, LA, USA
Donghui ZhangDepartment of Chemistry and Macromolecular Studies GroupLouisiana State UniversityBaton Rouge, LA, USA
1
Part I
Pseudo‐Peptides, Polyamino Acids, and Polyoxazolines
Polymers for Biomedicine: Synthesis, Characterization, and Applications, First Edition. Edited by Carmen Scholz. © 2017 John Wiley & Sons, Inc. Published 2017 by John Wiley & Sons, Inc.
3
1
1.1 Introduction
Materials made from polypeptides, and recently also polypeptoids, have received considerable and growing attention in recent years. Since synthetic polypeptides, just like natural proteins, are made up of amino acids, they can be non‐toxic, biocompatible, and degradable in the body while they remain stable in aqueous solution. The multitude of different side chains enables the design of peptidic superstructures like polyion complexes [1,2], polymer micelles [3,4], polymer vesicles [5,6], nanofibers or ‐tubes [7], and hydrogels [8].
Apart from exactly defined polypeptides (i.e., proteins) that show a defined sequence of amino acids, there are also natural polypeptides that resemble less defined classic synthetic polymers. One of these polypeptides is poly(ɣ‐glutamic acid) [9,10], which is produced by bacteria and cnidaria [11]. It is the major constituent of nattō (Japanese food from fermented soy beans) and approved by the FDA for cosmetic applications.
1.2 Synthesis of Poly(peptide)s
Synthetic polypeptides were first described by Leuchs in the beginning of the twentieth century, although their polymeric nature was not acknowledged at that time [12–14]. Many researchers have explored synthetic polypeptides through the twentieth century [15,16] partially with poor results regarding polymerization kinetics, end‐group integrity, or dispersity, in particular with more complex systems such as block copolypeptides, star‐like polypeptides, or bottle‐brush polymers. The reasons for this are manifold, including monomer
Characterization of Polypeptides and Polypeptoides – Methods and ChallengesDavid Huesmann and Matthias Barz
Institute of Organic Chemistry, Johannes Gutenberg‐Universität Mainz, Mainz, Germany
Polymers for Biomedicine4
purity, monomer instability over prolonged periods of time and the fact that the polymerization does not necessarily follow a single mechanism (Figure 1.1). The most prominent competing pathways are the normal amine mechanism (NAM, which leads to a classical chain growth) and the activated amine mech-anism (AMM, which leads to undefined polymers through condensation of polymer chains). Further, addition of an N‐carboxyanhydride, NCA, monomer
NH
OO O
R
H2NR′
AMM
NAM
N–
OO O
R
R′NH
OHN
R
OH
O
NH
OO O
R
–R′NH3+
R′NH
O
NH2
R
R′NH
O
NH2
R
N
OHN
R
O
O
OR
N
O
NH–
R
O
O
OR
O–
O
N
O
NH2
R
O
O
OR
N–
OO O
R
N
O–O
RC O
R′NH
O HN
R
O
O O
NH
R
OH
O
+NCA+NCA
+NCA
n
Isocyanate
Carbamate
NCA
RNH2
CondensationProducts
N
OHN
R
O
O
OR
+
+
n
H
R′NH
OHN
R
HN
O
OH
O
RUrea Derivative
Rearrangement–CO2
–CO2
–CO2
Figure 1.1 Mechanisms of NCA polymerization: Normal amine mechanism (NAM) and activated monomer mechanism (AMM).
Characterization of Polypeptides and Polypeptoides 5
before decarboxylation can lead to carbamates, which can rearrange into urea units, while a deprotonated NCA can open to form an isocyanate. A more in‐depth discussion of the reaction mechanism is outside of the focus of this chapter and can be found in excellent reviews and books [15–17].
The complex reaction mechanism has led to the development of controlled NCA polymerization methods starting in the end of the last century. In the late 1990s, the group of Timothy Deming was the first to demonstrate that the NCA polymerization using transition metal catalysts proceeds in a living man-ner and yields well‐defined polypeptides (Figure 1.2) [18]. While this approach has been very successful for the preparation of well‐defined and complex poly-peptide architectures [5,6,19], it has the need for a transition metal catalyst. Additionally, the synthesis of hybrid structures remains challenging since the transition metal catalyst needs to be modified [20].
As a complementary approach, Cheng and coworkers have reported silylated amine initiators, which allow control over NCA polymerization [22,23]. The trimethylsilyl residue remains at the polymer terminus over the course of the polymerization, allowing the preparation of defined polypeptides (Figure 1.3). The rate of polymerization is not slowed down by this polymerization tech-nique as the polymerization (M/I = 300) was reported to be completed within 24 h or less. Amine initiated polymerization has been reported to be complete
R
O
HNO
O
(L)nM
M = Co, Ni
+–CO
(L)n MR
HNO
O
NCA
–2 CO2
–CO2
NH
HNR
O
RNCA
HN
NHM(L)n
M(L)n
HN
R
O
O
R R
proton
migrationHNM(L)n
N
R O
NH
O
R
R
HNM(L)n
M(L)n
N
R O
Polymer
NCAM(L)n
N
NH
HN
R
R
O
O
Polymer
protonmigration HN N
R O
NH
O
Polymer
R
Initiation:
Propagation:
Figure 1.2 Initiation and propagation of metal catalyzed NCA polymerization. Source: Deming 2000 [21]. Reproduced with permission of American Chemical Society.
Polymers for Biomedicine6
within the same time frame (17 h for Xn = 438, poly(benzyl glutamic acid), (PGlu(OBn)) [24].
On the other hand, several approaches have been investigated to optimize the conditions of conventional amine initiated NCA polymerization. Vayaboury et al. used non‐aqueous capillary electrophoresis to show a dramatic increase of living chain ends by lowering the polymerization temperature to 0 °C [25]. Unfortunately, no GPC plots and polymer dispersities of the obtained poly-mers were presented. Heise and coworkers investigated the influence of reduced temperature further [26] and used vacuum for the removal of CO2 from the reaction to increase its speed [27]. CO2 liberation is a step in NCA polymerization, which depends highly on the pressure in the reaction vessel. Wooley and coworkers reported the removal of CO2 by nitrogen flow through the reaction mixture, thereby increasing also the polymerization speed [28]. Both findings are surprising since theoretical studies and experiments have shown that CO2 liberation is not the rate determining step of the polymeriza-tion [15,29–31]. However, the performed control polymerizations (no nitrogen flow) yielded polypeptides with high dispersities of 1.38 and 2.19 for Xn of 50 and 100, respectively, while dispersities of PGlu(OBn) initiated by primary amines are usually well below 1.2 [32].
Scholz and Vayaboury tackled the issue of different secondary structures in the growing peptide by introducing thiourea to suppress hydrogen‐bond for-mation [33]. It was found that the dispersity of polypeptides decreased mark-edly, independent of whether macroinitiators (PEG‐NH2) or low molar mass initiators (hexylamine) were used.
TMSTMS TMS
TMS
TMSTMS
NCA
SiMe3
Si
Si
Si
Si
HN
HN
HN
HN
R
O
O
O O
O
O
HN
O
OR
OO
OO
R O
O
ONH2
H2N
O
R
Si
O
O
O
O
R
R NH
NH
n
NH
NH
N
HN
HN
O
Figure 1.3 Mechanism of trimethylsilyl‐mediated NCA polymerization. Source: Lu 2007 [22]. Reproduced with permission of American Chemical Society.
Characterization of Polypeptides and Polypeptoides 7
In a different approach, Schlaad and coworkers introduced HCl salts of primary amines as initiators, lowering the reactivity of the growing chain end [34]. Elevated temperatures (40–80 °C) were used to counteract the slow polymeri-zation. This method was complemented by other ammonium salts, namely different acetates [35] and recently the non‐nucleophilic tetraflouroborates by Vicent and coworkers [36].
Finally, Hadjichristidis and coworkers reported on the use of highly puri-fied monomers, solvents and reagents under high vacuum techniques [24]. Interestingly, these results suggest that all the previously mentioned potential side reactions are impurity related and that control can be achieved by working with highly pure solvents, monomers, and initiators.
1.3 Characterization of Poly(peptide)s
The aim for better and better control over the NCA polymerization over the last century was also accompanied by the development of analytical methods that allowed for a better characterization of polypeptidic materials. As with many classes of polymers, polypeptides are often characterized by the most widely used analytical techniques NMR and GPC to determine composition, size and dispersity of the polymers. However, due to the periodical peptide bond in the polypeptide backbone, these polymers are often not in a random coil conformation – as is usually the case for other polymers. This leads to two major challenges in the characterization of polypeptides: (1) The secondary structures must be characterized using for example NMR, IR, CD spectros-copy, or X‐ray diffraction and (2) the different secondary structures lead to a change in the hydrodynamic radius of the polymers, limiting the usefulness of methods that rely on the hydrodynamic radius to deduce other physical parameters (e.g., GPC). It is worth noting, that these challenges do not apply to most polypeptoids, since they lack the free hydrogen at the amide bond and therefore do usually not form secondary structures.
The combination of a complex polymerization mechanism with many potential side reactions on one hand and challenging characterization on the other calls for extremely careful interpretation of obtained data. In the following sections, we will introduce different analytical methods for analyzing polypeptides highlighting their advantages and limitations.
1.4 Gel Permeation Chromatography (GPC)
Gel permeation chromatography is certainly one of the most important analy-sis methods in polymer chemistry yielding not only average molecular weights, but also a value for polymer dispersity, describing the width of the molecular
Polymers for Biomedicine8
weight distribution. However, these molecular weight distributions are often not obtained directly, but indirectly using a calibration by polymer standards.
The separation in the GPC column itself is enabled by polymer beads with different pore sizes. Large molecules cannot enter the pores and elute first from the columns, while smaller molecules can diffuse into the pores, thus remaining in the column for a longer time.
However, the separation does not occur by molecular weight, but by polymer size (i.e., hydrodynamic volume) and molecular weight is only inferred from calibration. To obtain correct molecular weights from this method, two condi-tions should be fulfilled: (1) The polypeptide has to be in one conformation and (2) the standards for the calibration have to be the same polymer (or at least very similar in structure) and have to exhibit the same secondary structure as the polymer measured.
Both conditions are virtually never fulfilled when working with polypeptides. Even very good solvents for polypeptides like dimethylformamide (DMF), dimethylacetamide (DMAc), N‐methylpyrolidone (NMP), and hexafluoroiso-propanol (HFIP) are usually not able to suppress secondary structures in pro-tected polypeptides, leading to a strong change in hydrodynamic volume [37]. Further, the standards used for calibration are in many cases poly(ethylene glycol) (PEG) or poly(methyl methacrylate) (PMMA), both molecular struc-tures are far from that of polypeptides (Figure 1.4).
Therefore, it appears reasonable to produce GPC standards for each class of polypeptides, as done by Hadjichristidis and coworkers. They synthesized nar-rowly distributed PGlu(OBn) and determined their molecular weight (Mn) by membrane osmometry. They then used these samples for the calibration of their GPC [24]. Using a calibration with polypeptide standards, the molecular weights from GPC measurements can be used to create a meaningful kinetic plot (Figure 1.5). Unfortunately, calibration with polypeptides is seldom per-formed, since polypeptide standards are not commercially available.
In some cases, bimodal molecular weight distributions can be observed due to a change in secondary structure, which results in a pronounced change in hydrodynamic volume. This can, for example, be seen in growing poly(N‐ ε‐benzyloxycarbonyl‐L‐lysine) (PLys(Z)) chains that undergo a transition in secondary structure at a degree of polymerization around 15 [37]. Observing the polymer at different time points of the polymerization shows a monomodal distribution (random coil) changing to a bimodal distribution when two secondary structures (random coil and α‐helix) are present (Figure 1.6). Once
O
PMMA PEG
OHN
R
O
Polypeptide
OH3C
Figure 1.4 Molecular structures of common GPC standards compared to polypeptides.
Characterization of Polypeptides and Polypeptoides 9
[M]/[I] = 52
[M]/[I] = 110
[M]/[I] = 223
[M]/[I] = 438
1,6 × 105
2.4 × 10–2
2.0 × 10–2
1.6 × 10–2
1.2 × 10–2
8.0 × 10–3
4.0 × 10–3
9.0 × 10–3 1.8 × 10–2 2.7 × 10–2 3.6 × 10–2 4.5 × 10–2 5.4 × 10–2
kp, o
bs (
1 m
ol–1
min
–1)
0.00.0
1,4 × 105
1,2 × 105
1,0 × 105
8,0 × 104
6,0 × 104
4,0 × 104
2,0 × 104
0,0
[M]/[I] = 743
[I], mol–1
10 20 30 40 50
Polymer conversion
60 70 80 90 100
Figure 1.5 Kinetic plot from the amine initiated polymerization of poly(glutamic acid). Molecular weights were obtained from GPC data, calibrated with poly(glutamic acid) standards. Source: Aliferis 2004 [24]. Reproduced with permission of American Chemical Society.
16 18 20
Vol/mL
Polymerizationtime1
0.8
0.6
0.4
0.2
0
RID
22 24 26 28
Figure 1.6 DMF GPC of a growing PLys(Z) chain showing the transition from random coil to α‐helix. Source: Huesmann 2014 [37]. Reproduced with permission of American Chemical Society.
Polymers for Biomedicine10
all chains have reached the appropriate length to form only α‐helices, the dis-tribution becomes monomodal again.
The same behavior is also visible for PLys(Z) of different degrees of polym-erization (Figure 1.7).
An estimation of the hydrodynamic radius (Rh) of a PLys(Z) random coil (worm‐like chain model) and α‐helix (cylinder) with DP = 15 shows an increase in hydrodynamic volume of α‐helix over random coil [37].
Taking this into account, it is clear that molecular weights of polypeptides from GPC have to be treated with extreme care. A molecular weight obtained with PMMA standards should never be treated as the real molecular weight of polypeptides, nor should every broadening or bimodal molecular weight dis-tributions be directly related to poorly defined polymers. Bimodal molecular weight distributions are not necessarily caused by side reactions but might be attributed to the coexistence of different secondary structures. Vice versa, it would not be wise to infer the coexistence of different secondary structures just from bimodal GPC distributions. Thus, in addition to standard GPC analytics it seems highly beneficial to investigate solution conformation by complementary characterization methods.
1
0.8
0.6
0.4
0.2
0
16 17 18 19 20 21
Vol/mL
PLys(Z)25
PLys(Z)50
PLys(Z)100
PLys(Z)200
RID
Figure 1.7 HFIP GPCs of PLys(Z), from right to left: P(Lys(Z)25, P(Lys(Z)50, P(Lys(Z)100, P(Lys(Z)200. Source: Huesmann 2014 [37]. Reproduced with permission of American Chemical Society.
Characterization of Polypeptides and Polypeptoides 11
1.5 Infrared (IR) Spectroscopy
Fourier transformed infrared (FT‐IR) spectroscopy is one of the oldest analyti-cal methods in organic chemistry and has become an established tool for the structural characterization of proteins. Using infrared light (wave numbers 4000–400 cm−1) vibrational modes in molecules are exited, leading to the absorption of light of a characteristic wavelength. Samples can be measured in solution or in the solid state. The use of attenuated total reflection (ATR) units allows easy measurements of small sample volumes.
For the analysis of polypeptides, the absorption of the amide I band (CO stretching, around 1650 cm−1) and amide II band (NH bending, CN stretching, around 1550 cm−1) are typically used. The typical amide I frequencies of protein secondary structures are shown in Table 1.1. α‐Helices show absorption between 1650–1657 cm−1, while random coils shift the absorption to lower wave numbers (1640–1651 cm−1) and turns show an adsorption at higher wave numbers (1655–1675 cm−1, 1680–1696 cm−1). The distinction of parallel and anti‐parallel β‐sheets is not easy, since their absorption is very similar. Parallel β‐sheets absorb at 1626–1640 cm−1 and anti‐parallel β‐sheets at 1612–1640 cm−1. However, anti‐parallel β‐sheets have a second, weak band at 1670–1690 cm−1, which allows discrimination between the two conformations. It should be stressed that these numbers are guidelines and may vary with changing amino acids [38,39].
IR spectra can of course only provide a qualitative picture of the secondary structures present in the polypeptide. Further, the bands are sensitive to the applied solvent and its water content. For the characterization of synthetic polypeptides organic solvents are often necessary to dissolve protected poly-peptides like DMF or DMAc. These solvents have strong amide bond
Table 1.1 Typical amide I frequencies of different secondary structures. Source: Pelton 2000 [40]. Reproduced with permission of Elsevier.
Conformation Amide I/cm−1
α‐helix 1650–1657
β‐sheet (anti‐parallel) 1612–1640,1670–1690 (weak)
β‐sheet (parallel) 1626–1640turn 1655–1675,
1680–1696random coil 1640–1651
Polymers for Biomedicine12
absorption bands themselves and can therefore not be used when looking at secondary structures. Water is also problematic, due to absorption at 1650 cm−1, which can be suppressed using high peptide concentrations, short path length and careful baseline subtraction. Urea and thiourea absorb between 1600–1700 cm−1 and also trifluoroacetates are problematic due to their absorption at 1673 cm−1. HFIP on the other hand, does not absorb between 1500–3000 cm−1 and can easily dissolve most polypeptides. Whenever measurements are per-formed in dry state, it should be kept in mind that there might be a pronounced change in secondary structure due to the absence of interaction with the solvent, which leads to a partial or complete collapse of the polypeptide.
Zhang and coworkers synthesized a mannose modified poly(glutamic acid) which, like its precursors, adopts an α‐helical conformation [41]. Among other techniques, IR spectroscopy was used to confirm this conformation in the solid state (Figure 1.8).
amide II amide I
D
D
C
1000 1500 2000 2500 3000 3500
Wave number (cm–1)
Abs
orba
nce
(a.u
.)
A BO O
ONaN3, DMF
60 °C, 48 hn
HN
Cl O O
O
PMEDTA, CuBrDMF, rt, 24 h
n
HN
N3 O O O
O
OH OH
OH
OH
OO
OOHHO
HOHO
n
HN
NN N
C
B
A
νC=O
νalkyne
νN=N=N
νC-H νO/N-H
νO-H
Figure 1.8 IR spectrum of mannose modified poly(glutamic acid) as well as its precursors, showing typical amide I and II bands of an α‐helical conformation. Source: Tang 2010 [41]. Reproduced with permission of American Chemical Society.
Characterization of Polypeptides and Polypeptoides 13
Scholz’s group investigated the secondary structure of oligopeptides [42]. IR was used to identify the different secondary structures of 20‐mers of protected lysine, cysteine, and glutamic acid. A shift of the amide I band can be seen between the α‐helical lysine and glutamic acid on one hand and the cysteine in a β‐sheet conformation on the other hand (Figure 1.9).
Another very useful application of IR spectroscopy in NCA polymerization lies in measuring the progress of the reaction. The monomer conversion can be easily visualized by the disappearance of the strong absorption band of the NCA at around 1860 and 1785 cm−1 (in DMF) (Figure 1.10).
Like FT‐IR spectroscopy, Raman spectra can be recorded by measuring the scattered instead of the absorbed light. In this case, different selection rules apply and different bands might be visible.
In conclusion, IR‐spectroscopy is a very powerful and easy to use tool to get a qualitative insight into the secondary structure of polypeptides, while quan-titative interpretation needs further treatment of the raw data by peak decon-volution and is strictly only applicable to natural proteins. When measuring in solution, the absorption of the solvent must be kept in mind, while the dry state may not represent the conformation of the polypeptide in solution.
N-hexylamino-p(L-Lys)
N-hexylamino-p(L-Cys)
N-hexylamino-p(L-Glu)
α-helixLysine
Cysteine
Glutamate
1850
3650 3150 2650 2150 1650 1150 650
95
85
75
65
55
45
1650 1450
α-helixβ-sheet
Figure 1.9 IR spectrum of protected lysine, cysteine, and glutamic acid 20‐mers. The arrows indicate the amide I band. Source: Ulkostki 2013 [42]. Reproduced with permission of American Chemical Society.
Polymers for Biomedicine14
1.6 Nuclear Magnetic Resonance (NMR) Spectroscopy
NMR spectroscopy is a complementary technique commonly used in polymer synthesis, as well as protein structure determination. The technique is based on the absorption of electromagnetic radiation by nuclei with a spin different from zero (1H, 13C, 15N) in a strong magnetic field. In this section, only the application of relatively simple 1D NMR experiments for the determination of chain length, composition, and secondary structure will be discussed. More complex or multidimensional NMR techniques for the determination of pro-tein tertiary structures like NOESY will not be discussed here but can be found in literature [43,44].
The simplest application is the determination of chain length, by comparing protons of the initiator or end group to protons of the repeating unit. To receive accurate results from this method, all chains need to carry the reference groups. To reference to the initiator, all chains should be started by the initiator and not by impurities in the solvent (e.g., water). For the end group the post polymeri-zation modification reaction performed needs to be quantitative. Further, the reference signals have to be well separated from the signals of the repeat unit to allow separate integration. To receive an accurate measurement even for larger polypeptides, a strong initiator signal is beneficial. Neopentylamine has proven to be a very reliable initiator that features nine equivalent protons,
Wavenumber (cm–1)
DMFMonomerin DMF
Polymerin DMF
Tra
nsm
ittan
ce
2000 1800 1600 1400 1200 1000 600800
1
0.8
0.6
0.4
0.2
1.2
1800 175018501900 900 8509501000
1.05
1
0.95
0.9
0.85
1.1
1.05
1
1.1
Figure 1.10 Useful IR NCA peaks to control monomer conversion (Lys(Z) in DMF).
Characterization of Polypeptides and Polypeptoides 15
which do not overlap with any amino acid signals [37]. Using this initiator, polypeptides with length of more then 420 repeating units can be identified by NMR as can be seen in Figure 1.11.
NMR spectroscopy can further be used to determine the secondary struc-ture of polypeptides in solution. Especially the α‐position of amino acids is very sensitive to changes in the secondary structure. This can be seen in the chemical shift of the α‐proton as well as the α‐carbon in 1H and 13C NMR spectroscopy, respectively [45–47]. The chemical shifts for 13Cα, 13Cβ, 13C’, 15N, 1HN, and 1Hα in α‐helix, β‐sheet, and random coil conformation have been collected and can be used for easy reference (Table 1.2) [47]. These chemical shifts given in Table 1.2 are attributed to unprotected amino acids in water, but only shift slightly when measuring protected polypeptides in organic solvents [37].
The effect of secondary structure in a growing PLys(Z) chain can be observed in Figure 1.12 (left). While the NMR spectrum shows two Hα peaks for short PLys(Z) the peak of the random coil disappears with increasing degree of polymerization.
13C‐NMR spectroscopy was extensively applied for the study of secondary structures in acetonitrile, TFA and in the solid state [48–50], as well as for sequence analysis [51] by Kricheldorf and coworkers. Figure 1.12 (right) shows a solid state 13C CP/MAS (cross polarization/magic angle spinning) NMR spectrum of poly(norvaline). The peaks corresponding to Cα, Cβ, and C’ show split peaks indicating the coexistence of α‐helix and β‐sheets.
O
HN
O
O
9 H
840 H
NHb
agg
g
f f
f e
NH20.82n
b
c
� (ppm)
b
d
a,b gfec
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
d
bb
b
Figure 1.11 NMR of poly(N‐ε‐benzyloxycarbonyl‐L‐lysine) (PLys(Z)), degree of polymerization 420, initiator: neopentylamine.
Table 1.2 Statistically derived chemical shifts in secondary structures. Source: Wishart 2011 [47]. Reproduced with permission of Elsevier.
13Cα13Cβ
13C’ 15N 1HN1Hα
Residue Helix Sheet Coil Helix Sheet Coil Helix Sheet Coil Helix Sheet Coil Helix Sheet Coil Helix Sheet Coil
Ala 54.8 51.5 52.8 18.3 21.1 19.1 179.4 176.1 177.7 121.4 124.5 123.6 8.08 8.44 8.15 4.03 4.77 4.26Cys (ox) 58.0 55.0 55.6 39.4 43.9 41.0 176.2 173.6 174.9 117.7 121.0 118.0 8.20 8.80 8.25 4.15 5.15 4.65Cys (red) 61.3 56.9 57.5 27.8 30.2 29.4 176.2 173.6 174.9 117.7 121.0 118.0 8.20 8.80 8.25 4.15 5.15 4.65Asp 56.7 53.9 54.2 40.5 42.3 40.9 178.0 175.5 176.3 119.2 122.2 120.0 8.18 8.51 8.36 4.43 4.94 4.60Glu 59.1 55.5 56.9 29.4 32.0 30.2 178.6 175.4 176.4 119.0 122.1 120.4 8.22 8.53 8.37 4.01 4.78 4.28Phe 60.8 56.7 58.0 38.8 41.5 39.5 177.1 174.3 175.6 119.2 121.1 119.7 8.18 8.75 8.17 4.16 5.09 4.54Gly 46.9 45.2 45.5 N/A N/A N/A 175.5 172.6 173.9 107.5 109.3 109.1 8.29 8.34 8.33 3.81 4.20 3.96His 59.0 55.1 55.9 29.5 31.9 30.0 177.0 174.2 174.8 118.0 120.5 118.7 8.10 8.62 8.21 4.33 5.06 4.53Ile 64.6 60.1 61.0 37.6 39.9 38.7 177.7 174.9 175.6 119.7 122.8 120.9 8.02 8.68 7.98 3.67 4.68 4.15Lys 58.9 55.4 56.6 32.3 34.6 32.8 178.4 175.3 176.3 119.2 122.2 120.5 7.99 8.48 8.23 3.99 4.69 4.26Leu 57.5 54.1 54.9 41.6 43.8 42.4 178.5 175.7 176.9 119.6 124.1 121.5 8.05 8.60 8.08 4.00 4.82 4.36Met 58.1 54.6 55.7 32.3 35.1 33.4 178.0 174.8 175.4 118.2 121.7 119.7 8.09 8.64 8.18 4.07 4.96 4.38Asn 55.5 52.7 53.2 38.6 40.1 38.6 176.9 174.6 175.1 117.3 121.6 118.2 8.22 8.60 8.40 4.48 5.06 4.66Pro 65.5 62.6 63.5 31.5 32.3 31.9 178.3 176.2 176.9 N/A N/A N/A N/A N/A N/A 4.22 4.60 4.37Gln 58.5 54.8 56.1 28.5 31.3 29.1 178.0 174.9 175.9 118.4 121.1 119.5 8.04 8.48 8.23 3.99 4.80 4.26Arg 58.9 55.1 56.4 30.1 32.2 30.7 178.3 175.1 176.0 118.9 122.3 120.4 8.07 8.56 8.25 3.99 4.74 4.24Ser 60.9 57.5 58.4 63.1 65.2 64.0 175.9 173.6 174.5 114.9 116.9 115.6 8.14 8.50 8.23 4.25 4.91 4.47Thr 65.6 61.1 61.6 68.9 70.8 70.1 175.9 173.7 174.7 114.6 116.5 113.4 8.04 8.51 8.16 4.00 4.86 4.45Val 66.2 60.8 62.1 31.5 33.9 32.7 177.7 174.8 175.7 119.2 121.9 119.8 8.02 8.62 8.04 3.58 4.60 4.12Trp 60.0 56.4 57.8 29.3 31.5 29.7 178.1 175.4 176.2 119.8 122.1 120.2 8.12 8.59 7.92 4.38 5.19 4.55Tyr 61.0 56.8 58.0 38.3 41.0 39.0 177.4 174.5 175.4 119.2 121.4 119.5 8.07 8.68 8.06 4.09 5.10 4.52